ASTELLAS PHARMA

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: -

Established: 2005-01-01

Employees: -

Market Cap: $22.5B

Website: https://www.astellas.com/

Clinical Trials

A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 Tablet

Phase 1

Completed

Conditions: Healthy Volunteer
Pharmacokinetics of YM150

Interventions: Drug: YM150

First Posted Date: 2010-05-18

Last Posted Date: 2010-05-25

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 24

Registration Number: NCT01125670

A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug

Phase 1

Completed

Conditions: Healthy
Pharmacokinetics of ASP1585

Interventions: Drug: ASP1585
Drug: 14C-Labeled ASP1585

First Posted Date: 2010-05-17

Last Posted Date: 2014-05-05

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 12

Registration Number: NCT01124747

A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment

Completed

Conditions: Overactive Bladder

First Posted Date: 2010-05-13

Last Posted Date: 2011-01-13

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 55

Registration Number: NCT01122563

Reproducibility Study of Overactive Bladder Symptom Score [OABSS]

Completed

Conditions: Overactive Bladder

First Posted Date: 2010-05-13

Last Posted Date: 2010-08-24

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 50

Registration Number: NCT01122550

A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects

Phase 2

Completed

Conditions: Mycoses

Interventions: Drug: placebo
Drug: micafungin

First Posted Date: 2010-05-13

Last Posted Date: 2024-11-19

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 252

Registration Number: NCT01122368

A Study to Assess Safety and Tolerability of ASP1941 After Single and Repeated Administration in Healthy Subjects

Phase 1

Completed

Conditions: Pharmacokinetics of ASP1941
Healthy Volunteer

Interventions: Drug: ASP1941
Drug: placebo

First Posted Date: 2010-05-12

Last Posted Date: 2010-05-12

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 84

Registration Number: NCT01121198

A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150

Phase 1

Completed

Conditions: Healthy
Pharmacokinetics of YM150

Interventions: Drug: YM150

First Posted Date: 2010-05-06

Last Posted Date: 2010-05-06

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 24

Registration Number: NCT01118559

A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain Patients

Phase 3

Completed

Conditions: Post Operative Pain

Interventions: Drug: etodolac
Drug: Placebo
Drug: YM177

First Posted Date: 2010-05-06

Last Posted Date: 2014-10-15

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 616

Registration Number: NCT01118572

A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus

Phase 2

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Placebo
Drug: ipragliflozin
Drug: Metformin

First Posted Date: 2010-05-05

Last Posted Date: 2024-11-06

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 343

Registration Number: NCT01117584

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy
Pharmacokinetics of Valsartan

Interventions: Drug: ASP1585
Drug: valsartan

First Posted Date: 2010-05-04

Last Posted Date: 2010-05-27

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 24

Registration Number: NCT01115972

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy